Cite
Helicobacter pylori infection prevents the occurrence of the tolerance phenomenon of histamine H2 receptor antagonists.
MLA
Fujisawa, T., et al. “Helicobacter Pylori Infection Prevents the Occurrence of the Tolerance Phenomenon of Histamine H2 Receptor Antagonists.” Alimentary Pharmacology & Therapeutics, vol. 20, no. 5, Sept. 2004, pp. 559–65. EBSCOhost, https://doi.org/10.1111/j.1365-2036.2004.02147.x.
APA
Fujisawa, T., Adachi, K., Komazawa, Y., Mihara, T., Azumi, T., Katsube, T., Furuta, K., Kazumori, H., & Kinoshita, Y. (2004). Helicobacter pylori infection prevents the occurrence of the tolerance phenomenon of histamine H2 receptor antagonists. Alimentary Pharmacology & Therapeutics, 20(5), 559–565. https://doi.org/10.1111/j.1365-2036.2004.02147.x
Chicago
Fujisawa, T., K. Adachi, Y. Komazawa, T. Mihara, T. Azumi, T. Katsube, K. Furuta, H. Kazumori, and Y. Kinoshita. 2004. “Helicobacter Pylori Infection Prevents the Occurrence of the Tolerance Phenomenon of Histamine H2 Receptor Antagonists.” Alimentary Pharmacology & Therapeutics 20 (5): 559–65. doi:10.1111/j.1365-2036.2004.02147.x.